Llwytho...
F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents
OBJECTIVE: To determine whether specific c-Mpl mutations might respond to thrombopoietin receptor agonists. METHODS: We created cell line models of type II c-Mpl mutations identified in CAMT. We selected F104S c-Mpl for further study because it exhibited surface expression of the receptor. We measur...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2862996/ https://ncbi.nlm.nih.gov/pubmed/20188141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2010.02.007 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|